Omnes Capital's investments: Enterome

Sector 
Pharma
Entry Date 
03/2012
Business 
Venture Capital

Enterome

Pioneer in personalised medicine harnessing the power of gut microbiome

Based in Paris, Enterome is an innovative theranostics company dedicated to discovering and developing biomarkers to diagnose and treat inflammatory conditions (Crohn’s disease, ulcerative colitis) linked to anomalies in intestinal composition using a unique platform that harnesses the power of the human microbiome. In addition to its inflammatory franchise, the Enterome platform can also be used for a vast range of applications such as monitoring and treating metabolic conditions (fatty liver, obesity, diabetes). 

Latest news